Endpoints News 生物医药· ENDPOINTS·· 25 天前AI 评分29
Aspen, Bambusa 目标 1.35 亿美元 IPO
Aspen, Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs
AI 导读
Aspen Neuroscience 和 Bambusa 均计划进行 1.35 亿美元的 IPO。
正文
Plus news about Hutchmed, Johnson & Johnson, Jazz Pharmaceuticals, Novartis, Roche and Oruka Therapeutics.
Aspen, Bambusa both eye $135M IPOs: Aspen Neuroscience
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news